Uber co-founder and CEO Travis Kalanick on Thursday ruled out a merger with rival domestic on-demand technology-enabled taxi services company, Ola, and said his company was in India for the ride.
“Although we are losing to Ola here in India, I do not forsee a merger with the company. We are in India for the long haul and will continue to invest and innovate to work towards a profitable future,” Kalanick told Niti Aayog CEO Amitabh Kant, when asked about Uber’s merger with Didi in China.
Kant and Kalanick were in conversation at the US India Business council-facilitated dialogue on the future of mobility in urban India.
“Uber was losing $200 million in China every month and hence it was tactful to go for a merger with Didi,” Kalanick said. He quipped that he was ready to become an Indian citizen if that would give the company a local image.
Uber sold off its China business to Didi in August this year. While Uber was last valued at $68 billion, after the deal Didi had a valuation of $35 billion.
“If we are to succeed in India, then we have to work towards being a firm for local people. It was one of the most important lessons we learnt from China,” Kalanick said.
Full Content: Hindustan Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas